在甲状腺恶性瘤中,放射治疗的现代景观
Adrija Ghosh1, Abhilash Dagar, Ram P Bharat
1Department of Radiation Oncology, National Cancer Institute, All India Institute of Medical Sciences, New Delhi, Delhi, India.
Journal of cancer research and therapeutics
|March 30, 2024
概括
甲状腺癌是一种常见的内分泌恶性瘤. 本综述探讨了放射治疗在治疗甲状腺癌方面的不足作用,以及手术和放射性治疗.
科学领域:
- 内分泌学 在内分泌学.
- 在瘤学瘤学.
背景情况:
- 甲状腺癌是最常见的内分泌恶性瘤,占印度新发癌症病例的1.5%.
- 甲状腺癌的发病率正在增加,部分原因是放射性成像的使用增加.
研究的目的:
- 审查目前放射治疗在治疗甲状腺癌中的作用.
- 突出辐射疗法作为潜在的未充分利用的治疗方式.
主要方法:
- 对甲状腺癌治疗研究的文献综述.
- 对放射治疗在甲状腺癌管理中的疗效和应用的分析.
主要成果:
- 手术是甲状腺癌的主要治疗方法.
- 放射性治疗对于差异化甲状腺癌至关重要.
- 辐射疗法是一种未被充分利用但潜在的有价值的治疗选择.
结论:
- 该审查强调了考虑放射治疗在甲状腺癌综合管理中的重要性.
- 进一步的研究和放射治疗的整合可以改善患者的治疗结果.
相关概念视频
Cancer Therapies
8.5K
Cancer therapies are various modes of treatment, such as surgery, radiation therapy, and chemotherapy that are administered to cancer patients.
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
8.5K
Targeted Cancer Therapies
7.0K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
There are several types of targeted therapies against...
7.0K
Positron Emission Tomography
6.2K
Positron emission tomography (PET) is a medical imaging technique involving radiopharmaceuticals — substances that emit short-lived radiation. Although the first PET scanner was introduced in 1961, it took 15 more years before radiopharmaceuticals were combined with the technique and revolutionized its potential.
One of the main requirements of a PET scan is a positron-emitting radioisotope, which is produced in a cyclotron and then attached to a substance used by the part of the body...
One of the main requirements of a PET scan is a positron-emitting radioisotope, which is produced in a cyclotron and then attached to a substance used by the part of the body...
6.2K
Tumor Immunotherapy
2.5K
Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
2.5K
Imaging Studies II: Positron Emission Tomography and Scintigraphy
853
Positron Emission Tomography (PET) is a medical imaging technique that provides crucial insights into the body's physiological functions at a molecular level. It is an indispensable resource for diagnosing, staging, and monitoring various illnesses, notably cancer, neurological disorders, and cardiovascular conditions.
Fundamental Principles of PET
Fundamental Principles of PET
853


